🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06663735
Starting soon Observational

Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

NCT06663735 · tracked via the Priya Life Science China tracker
Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Phase
Observational
Started
2024-10-30
Last updated
2024-10-29

Condition(s) studied

Uroepithelial Carcinoma

Study summary

A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Adults ≥18 years of age (at enrollment) * Histologically confirmed uroepithelial carcinoma * Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma * Complete medical history information Exclusion Criteria: * Incomplete medical history and medical records

Primary outcome measure(s)

Trial sites (11)

FacilityCityRegionStatus
Kaifeng City Center Hospital Kaifeng Henan
Luoyang Renda Hospital Luoyang Henan
Nanyang City Center Hospital Nanyang Henan
Qingfeng County People's Hospital Puyang Henan
Department of Oncology Xinxiang Henan
Hui County People's Hospital Xinxiang Henan
Jun County People's Hospital Xinxiang Henan
Qi County People's Hospital Xinxiang Henan
Xinxiang Allied Hospital Xinxiang Henan
Xinxiang Central Hospital Xinxiang Henan
The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan

More The First Affiliated Hospital of Xinxiang Medical College trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06663735 on ClinicalTrials.gov ↗ ← All trials in China